title: Updated treatment guidelines for gonorrhea infections.
abstract: Gonorrhea is the second most common bacterial sexually transmitted infection in the United States. It continues to be a major cause of morbidity for women and has been linked to infertility and pelvic inflammatory disease. In 2012, the Centers for Disease Control and Prevention revised the current treatment guidelines for gonorrhea in response to the rising rates of antibiotic resistance. This column will discuss the new guidelines, including the rationale for the change as well as nursing implications to support timely and effective treatment of gonorrhea.
authors.affiliation: Department of Nursing, School of Health and Environment, University of Massachusetts, Lowell, MA, USA. Heidi_Fantasia@ uml.edu
authors.forename: Heidi Collins
authors.initials: HC
authors.lastname: Fantasia
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001942:Breast Feeding; D002443:Ceftriaxone / Q000009:adverse effects / Q000627:therapeutic use*; D002487:Centers for Disease Control and Prevention, U.S.; D004342:Drug Hypersensitivity; D024881:Drug Resistance, Bacterial; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy* / Q000451:nursing*; D006801:Humans; D007273:Injections, Intramuscular; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D014481:United States
chemical_list: D000900:Anti-Bacterial Agents; D002443:Ceftriaxone